Meghmani Organics delivered remarkable financial performance in the June 2026 quarter, with consolidated net profit surging 280.05% to ₹48.19 crore compared to ₹12.68 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this represents a substantial improvement in the company's bottom-line performance despite facing revenue challenges. The profit surge of nearly 280% demonstrates the company's ability to significantly enhance profitability through operational efficiency and cost management measures.
The company experienced a 11.54% decline in sales to ₹542.83 crore in Q1 FY2027, down from ₹613.62 crore in the same quarter of the previous financial year. As reported by Business Standard, this revenue contraction indicates operational challenges despite the strong profit growth, suggesting improved cost management and operational efficiency during the quarter. The divergence between revenue and profit performance highlights the company's ability to maintain profitability through margin expansion despite lower sales volumes.
The company's EBITDA margin improved significantly to 18% in the June 2026 quarter compared to 10.9% in the corresponding quarter of the previous year. According to the latest financial data, EBITDA rose to ₹97.9 crore from ₹66.9 crore, representing a 46.3% increase year-on-year. The margin expansion of more than 700 basis points indicates a favorable swing in the spread between selling prices and raw material costs, where realisations held up or improved even as input costs eased, allowing far more of each rupee of sales to fall to profit despite lower overall revenue.
The cost structure improvements drove the margin expansion, with cost of materials consumed falling to ₹301.03 crore from ₹315.90 crore year-on-year. Additionally, finance costs dropped sharply to ₹13.05 crore from ₹29.47 crore, reflecting lower debt or reduced borrowing costs that added directly to the bottom line below the operating level. Other expenses also eased to ₹121.16 crore from ₹138.62 crore, contributing to the overall improvement in profitability metrics.
The sequential performance shows strong recovery momentum, with revenue rising 14.4% from ₹474.34 crore in the March quarter and profit before tax jumping from just ₹7.15 crore to ₹66.98 crore. As reported by Business Standard, the company was barely profitable in the March quarter and has bounced back sharply, pointing to a business emerging from a difficult patch. The combination of recovering EBITDA margin, sharply lower finance costs, and strong sequential rebound suggests the broader agrochemicals cycle is giving way to recovery in margins, though sustained topline recovery alongside margin gains would confirm the turnaround.
